BIOLASE, Inc. (BIOL)
USD 0.02
(27.39%)
USD 0.02
(27.39%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -15.13 Million USD | 39.06% |
| 2022 | -24.84 Million USD | -58.06% |
| 2021 | -15.71 Million USD | -13.7% |
| 2020 | -13.84 Million USD | 5.58% |
| 2019 | -14.63 Million USD | 15.16% |
| 2018 | -17.25 Million USD | -5.29% |
| 2017 | -16.32 Million USD | -20.66% |
| 2016 | -13.91 Million USD | 35.69% |
| 2015 | -19.76 Million USD | -17.71% |
| 2014 | -17.24 Million USD | -63.16% |
| 2013 | -10.39 Million USD | -334.45% |
| 2012 | -2.19 Million USD | 23.51% |
| 2011 | -3.39 Million USD | 68.14% |
| 2010 | -10.53 Million USD | -250.91% |
| 2009 | -1.33 Million USD | 40.04% |
| 2008 | -6.94 Million USD | 35.27% |
| 2007 | -7.62 Million USD | -211.82% |
| 2006 | -2.53 Million USD | 84.03% |
| 2005 | -15.74 Million USD | -811.9% |
| 2004 | -8.66 Million USD | -122.36% |
| 2003 | 7.32 Million USD | 205.24% |
| 2002 | 1.65 Million USD | 985.25% |
| 2001 | -993 Thousand USD | 91.98% |
| 2000 | -3.46 Million USD | 25.91% |
| 1999 | -4.63 Million USD | 54.11% |
| 1998 | -5 Million USD | -240.0% |
| 1997 | -2.8 Million USD | -25.0% |
| 1996 | -2.4 Million USD | -41.18% |
| 1995 | -1.7 Million USD | 56.41% |
| 1994 | -3.5 Million USD | 43.48% |
| 1993 | -6.9 Million USD | -30.19% |
| 1992 | -5.3 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3.86 Million USD | 12.36% |
| 2024 Q2 | -1.43 Million USD | 16.71% |
| 2023 Q3 | -3.66 Million USD | -41.39% |
| 2023 Q1 | -5.14 Million USD | 38.98% |
| 2023 Q4 | -4.41 Million USD | -20.22% |
| 2023 FY | - USD | 39.06% |
| 2023 Q2 | -2.59 Million USD | 49.53% |
| 2022 Q2 | -4.92 Million USD | -20.45% |
| 2022 Q4 | -8.42 Million USD | -11.93% |
| 2022 FY | - USD | -58.06% |
| 2022 Q3 | -7.52 Million USD | -52.87% |
| 2022 Q1 | -4.08 Million USD | 5.0% |
| 2021 Q3 | -2.52 Million USD | 19.13% |
| 2021 Q4 | -4.3 Million USD | -70.59% |
| 2021 FY | - USD | -13.7% |
| 2021 Q1 | -5.97 Million USD | -8.02% |
| 2021 Q2 | -3.12 Million USD | 47.8% |
| 2020 Q3 | 581 Thousand USD | 114.6% |
| 2020 Q2 | -3.97 Million USD | 23.11% |
| 2020 Q1 | -5.17 Million USD | -83.51% |
| 2020 FY | - USD | 5.58% |
| 2020 Q4 | -5.53 Million USD | -1052.32% |
| 2019 Q4 | -2.82 Million USD | 39.45% |
| 2019 FY | - USD | 15.16% |
| 2019 Q2 | -3.25 Million USD | 16.85% |
| 2019 Q1 | -3.91 Million USD | -8.96% |
| 2019 Q3 | -4.65 Million USD | -43.03% |
| 2018 Q1 | -4.92 Million USD | -37.89% |
| 2018 FY | - USD | -5.29% |
| 2018 Q4 | -3.59 Million USD | 15.12% |
| 2018 Q3 | -4.23 Million USD | 9.51% |
| 2018 Q2 | -4.67 Million USD | 4.9% |
| 2017 Q1 | -3.78 Million USD | -6.89% |
| 2017 Q3 | -4.62 Million USD | -4.88% |
| 2017 Q4 | -3.56 Million USD | 22.85% |
| 2017 FY | - USD | -20.66% |
| 2017 Q2 | -4.41 Million USD | -16.51% |
| 2016 FY | - USD | 35.69% |
| 2016 Q4 | -3.54 Million USD | -11.63% |
| 2016 Q3 | -3.17 Million USD | -6.26% |
| 2016 Q2 | -2.98 Million USD | 28.45% |
| 2016 Q1 | -4.17 Million USD | -97.44% |
| 2015 Q3 | -5.11 Million USD | 25.42% |
| 2015 Q4 | -2.11 Million USD | 58.72% |
| 2015 FY | - USD | -17.71% |
| 2015 Q2 | -6.86 Million USD | -14.59% |
| 2015 Q1 | -5.99 Million USD | -56.85% |
| 2014 FY | - USD | -63.16% |
| 2014 Q2 | -6.01 Million USD | -34.87% |
| 2014 Q3 | -3.29 Million USD | 45.22% |
| 2014 Q4 | -3.81 Million USD | -15.9% |
| 2014 Q1 | -4.46 Million USD | -120.14% |
| 2013 Q4 | -2.02 Million USD | 45.54% |
| 2013 Q3 | -3.72 Million USD | -62.3% |
| 2013 Q2 | -2.29 Million USD | 18.64% |
| 2013 Q1 | -2.81 Million USD | -336.33% |
| 2013 FY | - USD | -334.45% |
| 2012 FY | - USD | 23.51% |
| 2012 Q4 | 1.19 Million USD | 407.22% |
| 2012 Q3 | -388 Thousand USD | 75.61% |
| 2012 Q2 | -1.59 Million USD | -6.35% |
| 2012 Q1 | -1.49 Million USD | 17.35% |
| 2011 Q1 | -178 Thousand USD | -128.03% |
| 2011 Q2 | -534 Thousand USD | -200.0% |
| 2011 Q3 | -787 Thousand USD | -47.38% |
| 2011 Q4 | -1.81 Million USD | -129.99% |
| 2011 FY | - USD | 68.14% |
| 2010 Q3 | -2.16 Million USD | 43.79% |
| 2010 Q4 | 635 Thousand USD | 129.34% |
| 2010 Q1 | -5 Million USD | -359.45% |
| 2010 FY | - USD | -250.91% |
| 2010 Q2 | -3.85 Million USD | 23.12% |
| 2009 Q4 | -1.09 Million USD | -186.85% |
| 2009 Q2 | 2.83 Million USD | 162.85% |
| 2009 FY | - USD | 40.04% |
| 2009 Q3 | 1.25 Million USD | -55.75% |
| 2009 Q1 | -4.51 Million USD | -31.32% |
| 2008 Q2 | 640 Thousand USD | 191.95% |
| 2008 Q1 | -696 Thousand USD | 68.93% |
| 2008 Q3 | -1.44 Million USD | -325.78% |
| 2008 FY | - USD | 35.27% |
| 2008 Q4 | -3.43 Million USD | -137.79% |
| 2007 Q3 | -3.23 Million USD | -455.94% |
| 2007 FY | - USD | -211.82% |
| 2007 Q2 | -581 Thousand USD | 63.13% |
| 2007 Q1 | -1.57 Million USD | -199.75% |
| 2007 Q4 | -2.24 Million USD | 30.65% |
| 2006 Q1 | -1.34 Million USD | -440.56% |
| 2006 FY | - USD | 84.03% |
| 2006 Q3 | -808 Thousand USD | 56.84% |
| 2006 Q4 | 1.58 Million USD | 295.54% |
| 2006 Q2 | -1.87 Million USD | -39.08% |
| 2005 FY | - USD | -811.9% |
| 2005 Q4 | -249 Thousand USD | 94.9% |
| 2005 Q3 | -4.88 Million USD | 18.74% |
| 2005 Q2 | -6.01 Million USD | -46.59% |
| 2005 Q1 | -4.1 Million USD | -125.27% |
| 2004 FY | - USD | -122.36% |
| 2004 Q3 | -2.26 Million USD | -317.94% |
| 2004 Q1 | 1.36 Million USD | -51.48% |
| 2004 Q2 | 1.03 Million USD | -23.92% |
| 2004 Q4 | -1.82 Million USD | 19.47% |
| 2003 FY | - USD | 205.24% |
| 2003 Q2 | 1.19 Million USD | 103.42% |
| 2003 Q1 | 951 Thousand USD | -42.19% |
| 2003 Q3 | 2.54 Million USD | 122.35% |
| 2003 Q4 | 2.93 Million USD | 6.16% |
| 2002 Q2 | 564 Thousand USD | 215.29% |
| 2002 Q4 | 1.11 Million USD | 26.34% |
| 2002 Q1 | 173 Thousand USD | -57.57% |
| 2002 Q3 | 437 Thousand USD | 61.82% |
| 2002 FY | - USD | 985.25% |
| 2001 FY | - USD | 91.98% |
| 2001 Q3 | 115.52 Thousand USD | 194.96% |
| 2001 Q1 | -643.39 Thousand USD | -22.56% |
| 2001 Q2 | -87.95 Thousand USD | 86.33% |
| 2001 Q4 | 417 Thousand USD | 343.0% |
| 2000 Q1 | -990.06 Thousand USD | 51.37% |
| 2000 Q4 | -524.96 Thousand USD | 52.28% |
| 2000 FY | - USD | 25.91% |
| 2000 Q3 | -1.09 Million USD | -29.03% |
| 2000 Q2 | -852.51 Thousand USD | 13.89% |
| 1999 FY | - USD | 54.11% |
| 1999 Q1 | -700 Thousand USD | 58.82% |
| 1999 Q2 | -1.19 Million USD | -71.43% |
| 1999 Q3 | -800 Thousand USD | 33.33% |
| 1999 Q4 | -2.03 Million USD | -154.47% |
| 1998 Q1 | -800 Thousand USD | 0.0% |
| 1998 FY | - USD | -240.0% |
| 1998 Q2 | -1.2 Million USD | -50.0% |
| 1998 Q3 | -1.4 Million USD | 408.33% |
| 1998 Q4 | -1.7 Million USD | -145.95% |
| 1997 Q1 | -800 Thousand USD | 0.0% |
| 1997 FY | - USD | -25.0% |
| 1997 Q4 | -800 Thousand USD | -60.0% |
| 1997 Q3 | -500 Thousand USD | 44.44% |
| 1997 Q2 | -800 Thousand USD | -12.5% |
| 1996 Q2 | -400 Thousand USD | 20.0% |
| 1996 Q1 | -600 Thousand USD | -66.67% |
| 1996 FY | - USD | -41.18% |
| 1996 Q4 | -800 Thousand USD | -33.33% |
| 1996 Q3 | -600 Thousand USD | -50.0% |
| 1995 Q4 | -300 Thousand USD | -50.0% |
| 1995 Q2 | -400 Thousand USD | 42.86% |
| 1995 Q1 | -700 Thousand USD | 46.15% |
| 1995 Q3 | -200 Thousand USD | 50.0% |
| 1995 FY | - USD | 56.41% |
| 1994 Q2 | -400 Thousand USD | -300.0% |
| 1994 Q4 | -1.4 Million USD | -62.5% |
| 1994 Q3 | -800 Thousand USD | -100.0% |
| 1994 Q1 | 200 Thousand USD | 108.7% |
| 1994 FY | - USD | 43.48% |
| 1993 Q4 | -2.3 Million USD | -64.29% |
| 1993 FY | - USD | -30.19% |
| 1993 Q3 | -1.4 Million USD | 17.65% |
| 1993 Q2 | -1.7 Million USD | -21.43% |
| 1993 Q1 | -1.4 Million USD | 39.13% |
| 1992 FY | - USD | 0.0% |
| 1992 Q4 | -2.3 Million USD | -130.0% |
| 1992 Q2 | -1.2 Million USD | -185.71% |
| 1992 Q3 | -1 Million USD | 16.67% |
| 1992 Q1 | 1.4 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -12.249% |
| Cerus Corporation | -26.53 Million USD | 42.949% |
| OrthoPediatrics Corp. | -8.38 Million USD | -80.635% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -44.257% |
| Talis Biomedical Corporation | -66.04 Million USD | 77.078% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 9.211% |
| Inogen, Inc. | -45.67 Million USD | 66.858% |
| Spectral AI, Inc. | -12.26 Million USD | -23.463% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 68.257% |
| CVRx, Inc. | -38.73 Million USD | 60.912% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -329.11% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -25.043% |
| Orthofix Medical Inc. | -86.98 Million USD | 82.596% |
| Venus Concept Inc. | -26.11 Million USD | 42.025% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 69.583% |
| Bioventus Inc. | -23.07 Million USD | 34.378% |
| BrainsWay Ltd. | -2.31 Million USD | -555.084% |
| Envoy Medical, Inc. | -18.23 Million USD | 16.992% |
| electroCore, Inc. | -17.76 Million USD | 14.758% |
| IceCure Medical Ltd | -15.25 Million USD | 0.747% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 69.57% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 10.185% |
| MaxCyte, Inc. | -44.12 Million USD | 65.693% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -28.777% |
| Nexalin Technology, Inc. | -5.69 Million USD | -165.968% |
| PAVmed Inc | -75.74 Million USD | 80.012% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 71.839% |
| RxSight, Inc. | -41.03 Million USD | 63.109% |
| Sight Sciences, Inc. | -49.41 Million USD | 69.364% |
| SI-BONE, Inc. | -34.44 Million USD | 56.05% |
| TELA Bio, Inc. | -40.63 Million USD | 62.742% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 74.032% |
| Treace Medical Concepts, Inc. | -39 Million USD | 61.19% |
| LivaNova PLC | 39.01 Million USD | 138.802% |
| 908 Devices Inc. | -34.02 Million USD | 55.506% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 86.311% |
| Nemaura Medical Inc. | -7.28 Million USD | -107.752% |
| NeuroPace, Inc. | -22.83 Million USD | 33.7% |
| LENSAR, Inc. | -8.71 Million USD | -73.732% |
| Apyx Medical Corporation | -18.11 Million USD | 16.415% |
| Cutera, Inc. | -136.56 Million USD | 88.914% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -347.899% |
| BioSig Technologies, Inc. | -28.15 Million USD | 46.222% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 701.709% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 27.872% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 103.947% |
| Axonics, Inc. | 7.77 Million USD | 294.714% |
| Outset Medical, Inc. | -153.78 Million USD | 90.156% |
| IRIDEX Corporation | -7.44 Million USD | -103.263% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 84.567% |
| IRadimed Corporation | 20.8 Million USD | 172.781% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -87.782% |
| INVO Bioscience, Inc. | -6.88 Million USD | -120.043% |
| Telesis Bio, Inc. | -40.49 Million USD | 62.613% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 141.277% |
| Varex Imaging Corporation | 67.2 Million USD | 122.528% |
| Quipt Home Medical Corp. | 44.07 Million USD | 134.351% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -39.273% |
| Pulmonx Corporation | -55.09 Million USD | 72.521% |
| Dynatronics Corporation | -976 Thousand USD | -1451.114% |
| Modular Medical, Inc. | -17.1 Million USD | 11.483% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -4.515% |
| Semler Scientific, Inc. | 23.58 Million USD | 164.178% |
| InMode Ltd. | 196.28 Million USD | 107.713% |
| Bruker Corporation | 599 Million USD | 102.527% |
| Cytosorbents Corporation | -28.81 Million USD | 47.454% |
| DexCom, Inc. | 916.7 Million USD | 101.651% |
| Align Technology, Inc. | 799.03 Million USD | 101.895% |
| Viveve Medical, Inc. | -20.61 Million USD | 26.57% |
| ZimVie Inc. | 91.07 Million USD | 116.623% |
| Movano Inc. | -29.12 Million USD | 48.021% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -243.444% |
| Nexalin Technology, Inc. | -5.69 Million USD | -165.968% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -329.11% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 92.223% |
| Profound Medical Corp. | -27.12 Million USD | 44.185% |
| Insulet Corporation | 323.6 Million USD | 104.678% |
| enVVeno Medical Corporation | -25.01 Million USD | 39.488% |
| Surmodics, Inc. | 1.18 Million USD | 1374.327% |
| iCAD, Inc. | -6.56 Million USD | -130.602% |
| Nuwellis, Inc. | -16.35 Million USD | 7.441% |
| Biotricity, Inc. | -8.82 Million USD | -71.483% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 84.371% |
| Aethlon Medical, Inc. | -11.84 Million USD | -27.765% |
| InspireMD, Inc. | -20.91 Million USD | 27.603% |
| PAVmed Inc. | -75.74 Million USD | 80.012% |
| Beyond Air, Inc. | -59.03 Million USD | 74.354% |
| FONAR Corporation | 28.25 Million USD | 153.586% |
| AxoGen, Inc. | -13.32 Million USD | -13.588% |
| Vivani Medical, Inc. | -26.6 Million USD | 43.104% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 161.689% |
| Inari Medical, Inc. | 7.11 Million USD | 312.836% |
| UFP Technologies, Inc. | 72.74 Million USD | 120.812% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -347.134% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -145.923% |
| Tenon Medical, Inc. | -15.52 Million USD | 2.505% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 0.832% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 63.499% |
| AdaptHealth Corp. | -171.09 Million USD | 91.151% |
| Sintx Technologies, Inc. | -6.6 Million USD | -129.379% |
| NanoVibronix, Inc. | -3.43 Million USD | -340.728% |
| Quanterix Corporation | -38.08 Million USD | 60.253% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -39.273% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 50563.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 94.54% |
| TransMedics Group, Inc. | -7.6 Million USD | -99.119% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 30.443% |
| NeuroMetrix, Inc. | -7.09 Million USD | -113.351% |
| Hyperfine, Inc. | -47.06 Million USD | 67.831% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 74.036% |
| Biomerica, Inc. | -5.99 Million USD | -152.611% |
| Bone Biologics Corporation | 479.57 Thousand USD | 3256.773% |
| AVITA Medical, Inc. | -39.56 Million USD | 61.739% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -65.04% |
| Silk Road Medical, Inc | -45.08 Million USD | 66.417% |